Neutrophil counts in persons of African origin.

aHIV Pathogenesis Programme, Doris Duke Medical Research Institute bKwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa cRagon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Boston, Massachusetts, USA dMax Planck Institute for Infection Biology, Berlin, Germany.
Current opinion in hematology (Impact Factor: 4.05). 11/2013; DOI: 10.1097/MOH.0000000000000007
Source: PubMed

ABSTRACT The causes of ethnic or benign neutropenia have long been unclear. Here, we discuss the emerging data on the causes and consequences of neutropenia and discuss the relevance of these data for African populations, in which the prevalence of neutropenia is high.
Genetic deletion of the Duffy antigen receptor for chemokines (DARC-null genotype) has been identified as a major determinant for neutropenia. DARC acts as a receptor for Plasmodium vivax malaria and the DARC-null genotype has thus been positively selected among Africans; however, recent studies suggest that Duffy-null-linked neutropenia could increase the risk of HIV infection. Data are emerging that neutrophils are versatile cells that play a critical role not only in direct antimicrobial activity but also in priming and regulating the activity of other innate and adaptive immune cells. Therefore, we discuss here the imperative to better understand the causes, consequences, and the underlying mechanisms of neutropenia among Africans as a prerequisite for rational and optimal biomedical interventions to improve health outcomes.
Neutropenia among Africans, linked to the Duffy-null trait or otherwise, may have significant health consequences that remain largely undetermined and could have a significant impact on the pathogenesis of diseases.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Benign familial leukopenia (BFL) is a hereditary phenomenon, encountered in several ethnic groups. Subjects bearing BFL are believed to be affected by bacterial infection in no greater incidence than normal subjects. In our study we investigated a group of subjects with BFL during an acute bacterial infection in comparison to subjects without BFL with the same infection. We found that the subjects with BFL had no absolute leukocytosis during the infection. Nevertheless, they reacted similarly to the other subjects in regard to their temperature and heart rate; however, they were hospitalized for fewer days than subjects without BFL. We conclude that BFL is a benign phenomenon, requiring neither specific treatment as such, nor more aggressive therapy during infection. The benign course of an acute bacterial infection in BFL indicates that perhaps the number of WBC's that are normally recruited during an infection in normal subjects highly exceeds that which is necessary.
    Biomedecine [?] Pharmacotherapy 02/1985; 39(1):23-6. · 2.11 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: It appears likely that neutropenia is a normal genetically determined characteristic of many indigenous African peoples. A similar genetically determined neutropenia occurs among Jews of Yemenite origin, possibly owing to an African genetic contribution to the Yemenite population. The eosinophilia in communities living in the tropics is not related in any direct way to the neutropenia, and probably results from intestinal parasitic infestation.
    The Lancet 12/1971; 2(7732):1021-3. DOI:10.1016/S0140-6736(71)90335-7 · 39.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Plasmodium vivax and P. falciparum are the major causes of human malaria, except in sub-Saharan Africa where people lack the Duffy blood group antigen, the erythrocyte receptor for P. vivax. Duffy negative human erythrocytes are resistant to invasion by P. vivax and the related monkey malaria, P. knowlesi. Several lines of evidence in the present study indicate that the Duffy blood group antigen is the erythrocyte receptor for the chemokines interleukin-8 (IL-8) and melanoma growth stimulatory activity (MGSA). First, IL-8 binds minimally to Duffy negative erythrocytes. Second, a monoclonal antibody to the Duffy blood group antigen blocked binding of IL-8 and other chemokines to Duffy positive erythrocytes. Third, both MGSA and IL-8 blocked the binding of the parasite ligand and the invasion of human erythrocytes by P. knowlesi, suggesting the possibility of receptor blockade for anti-malarial therapy.
    Science 09/1993; 261(5125):1182-4. DOI:10.1126/science.7689250 · 31.48 Impact Factor